re: Research Thread- Space Edition

S-1 is the prospectus filed post deSPAC that has the shares, unit holders, etc. It's the document that these short squeeze chasers look at to see how "tight" the float is going to be.

Warrants are like extremely long dated options, usually 5-10 years to expiration. They give you the right to buy company stock above a certain price, usually $11.50 per share, until the expiration date. Usually if the share price goes above $18.50 for 20 out of 30 trading days, then the company can call in the warrants and force you to exercise them (that's why I am heavily in warrants in my tax advantaged accounts as owning them in your brokerage account can result in a forced short term cap gain). They can be "good" if you are extremely convinced that the stock price is going up in price and want a levered play compared to owning commons, similar to options. Biotech warrants trade at a very high premium as folks assume that there will be a huge spike that will send the shares way above $18.50 if the company "hits." But the downside of warrants is you can lose everything if the company price doesn't go up over time, while with commons you have much more protected downside.

RDW does not have debt and has a boatload of cash that is about to be deployed in M&A deals actually.